Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.

Autor: Martínez-Lago N; Medical Oncology Department, University Hospital A Coruña, A Coruña, Spain., Cameselle García S; Medical Oncology Department, Ourense University Hospital Complex, Ourense, Spain., Alonso de Castro B; Medical Oncology Department, University Hospital A Coruña, A Coruña, Spain., Gómez-Randulfe Rodríguez MI; Medical Oncology Department, University Hospital A Coruña, A Coruña, Spain., Carmona Campos M; Medical Oncology Department, University Hospital Lucus Augusti, Lugo, Spain., González Villarroel P; Medical Oncology Department, Alvaro Cunqueiro University Hospital, Vigo, Spain., Salgado Fernández M; Medical Oncology Department, Ourense University Hospital Complex, Ourense, Spain., De la Cámara Gómez JC; Medical Oncology Department, University Hospital A Coruña, A Coruña, Spain., Romero Reinoso C; Medical Oncology Department, POVISA, Vigo, Spain., Cousillas Castiñeiras A; Medical Oncology Department, Pontevedra University Hospital Complex, Pontevedra, Vigo, Spain., Méndez Méndez JC; Medical Oncology Department, Centro Oncológico de Galicia, A Coruña, Spain., Vidal Insua Y; Medical Oncology Department, Santiago University Hospital Complex, Santiago de Compostela, A Coruña, Spain., Fernández-Montes A; Medical Oncology Department, Ourense University Hospital Complex, Ourense, Spain.

Publikováno v: PloS one [PLoS One] 2022 Jun 03; Vol. 17 (6), pp. e0269399. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022).

Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.

Autor: Martínez-Lago N; Medical Oncology Department, University Hospital A Coruña, Xubias de Arriba, 84, 15006, A Coruña, Galicia, Spain. Nieves.Purificacion.Martinez.Lago@sergas.es., Fernández-Montes A; Complexo Hospitalario Universitario de Ourense, Ourense, Galicia, Spain., Covela M; Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain., Brozos EM; Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain., De la Cámara J; Complexo Hospitalario Universitario de Ferrol, Ferrol, Galicia, Spain., Méndez Méndez JC; Sanatorio Nosa Señora dos Ollos Grandes, Lugo, Galicia, Spain., Jorge-Fernández M; Hospital Universitario Álvaro Cunqueiro, Vigo, Pontevedra, Spain., Cousillas Castiñeiras A; Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Reboredo C; Medical Oncology Department, University Hospital A Coruña, Xubias de Arriba, 84, 15006, A Coruña, Galicia, Spain., Arias Ron D; Complexo Hospitalario Universitario de Ourense, Ourense, Galicia, Spain., Pellón Augusto ML; Complexo Hospitalario Universitario de Ferrol, Ferrol, Galicia, Spain., González Villarroel P; Hospital Universitario Álvaro Cunqueiro, Vigo, Pontevedra, Spain., Graña B; Medical Oncology Department, University Hospital A Coruña, Xubias de Arriba, 84, 15006, A Coruña, Galicia, Spain., Salgado Fernández M; Complexo Hospitalario Universitario de Ourense, Ourense, Galicia, Spain., Carral Maseda A; Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain., Vázquez Rivera F; Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain., Candamio Folgar S; Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain., Reboredo López M; Medical Oncology Department, University Hospital A Coruña, Xubias de Arriba, 84, 15006, A Coruña, Galicia, Spain.

Publikováno v: BMC cancer [BMC Cancer] 2021 Jan 14; Vol. 21 (1), pp. 64. Date of Electronic Publication: 2021 Jan 14.

Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram.

Autor: Fernandez Montes A; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, C/Calle Ramon Puga Noguerol, 54, s/n, 32005, Ourense, Spain. afm1003@hotmail.com., Vazquez Rivera F; Medical Oncology Department, Hospital Clínico Universitario de Santiago, Rúa da Choupana, s/n, 15706, Santiago, A Coruña, Spain., Martinez Lago N; Medical Oncology Department, Hospital Universitario A Coruña, C/As Xubias, s/n, 15006, A Coruña, Spain., Covela Rúa M; Medical Oncology Department, Hospital Universitario Lucus Augusti, C/Dr. Ulises Romero, 1, 27003, Lugo, Spain., Cousillas Castiñeiras A; Medical Oncology Department, Hospital Provincial de Pontevedra, C/Loureiro Crespo, 2, 36002, Pontevedra, Spain., Gonzalez Villarroel P; Medical Oncology Department, Hospital Universitario Álvaro Cunqueiro, C/Estrada de Clara Campoamor, 341, 36312, Vigo, Pontevedra, Spain., de la Cámara Gómez J; Medical Oncology Department, Hospital Universitario Arquitecto Marcide, Av. da Residencia, s/n, 15405, El Ferrol, A Coruña, Spain., Méndez Méndez JC; Medical Oncology Department, Centro Oncológico de Galicia, Rúa Doctor Camilo Veiras, 1, 15009, A Coruña, Spain., Salgado Fernández M; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, C/Ramón Puga, s/n, 32005, Ourense, Spain., Candamio Folgar S; Medical Oncology Department, Hospital Clínico Universitario de Santiago, Rúa da Choupana, s/n, 15706, Santiago, A Coruña, Spain., Reboredo López M; Medical Oncology Department, Hospital Universitario A Coruña, C/As Xubias, s/n, 15006, A Coruña, Spain., Carmona Campos M; Medical Oncology Department, Hospital Universitario Lucus Augusti, C/Dr. Ulises Romero, 1, 27003, Lugo, Spain., Gallardo Martín E; Medical Oncology Department, Hospital Provincial de Pontevedra,, C/Loureiro Crespo, 2, 36002, Pontevedra, Spain., Jorge Fernández M; Medical Oncology Department, Hospital Universitario Álvaro Cunqueiro, C/Estrada de Clara Campoamor, 341, 36312, Vigo, Pontevedra, Spain., Pellón Augusto ML; Medical Oncology Department, Hospital Universitario Arquitecto Marcide, Av. da Residencia, s/n, 15405, El Ferrol, A Coruña, Spain., París Bouzas L; Medical Oncology Department, Centro Oncológico de Galicia, Rúa Doctor Camilo Veiras, 1, 15009, A Coruña, Spain., García Gómez J; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense,, C/Calle Ramon Puga Noguerol, s/n, 32005, Ourense, Spain.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2020 Mar; Vol. 22 (3), pp. 351-359. Date of Electronic Publication: 2019 May 09.